What this study is
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.
What's being tested
- Specimen protocol
Intervention · OTHER
The research specimen will be obtained from the residual specimen that would otherwise be discarded per usual hospital procedure.
Study details
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Conditions
- Sarcoma
- Enrolling
- 3,000 people
- Starts
- 2002-06
- Est. completion
- 2027-06
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- All patients with known or suspected sarcoma who will have or have had tissue removed for therapeutic or diagnostic purposes.
- Patients will be entered without preference for any particular racial/ethnic group or gender.
- Patients may have received prior hormonal therapy, cytotoxic chemotherapy, irradiation, immunotherapy or surgical therapy.
- Tissue specimens must be large enough in quantity to allow routine pathologic analysis, with the research laboratory specimen removed from the residual specimen, which would otherwise be discarded. Optimal tissue amounts for snap freeze: Core biopsy - 2 tissue cores Incisional biopsy- 0.5 to 1.5 grams Resected sarcoma specimen- 1.0 to 50 grams depending on size of specimen Normal fat or muscle tissue - 0.5 to 4.0 grams (if available from resected sarcoma specimen) Optimal tissue amounts for RNA later Core biopsy - 2 tissue cores Incisional biopsy- 30 mg (three 3 x 3 x 3 mm cubes) Resected sarcoma specimen - 30 mg (three 3 x 3 x 3 mm cubes) Normal fat or muscle tissue - 30 mg (three 3 x 3 x 3 mm cube
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (7)
7 openContact for 5 of 7 open sites
- Samuel Singer, MD · Contact212-639-2940
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
Basking Ridge, New Jersey, United States
RecruitingMemorial Sloan Kettering Monmouth (Consent and Followup)
Middletown, New Jersey, United States
RecruitingMemorial Sloan Kettering Bergen (Consent and Follow up)
Montvale, New Jersey, United States
- Sam Singer, MD · Contact212-639-2940
RecruitingMemorial Sloan Kettering Commack (Consent and Follow-Up)
Commack, New York, United States
RecruitingMemorial Sloan Kettering Westchester (Consent and Followup)
Harrison, New York, United States
RecruitingMemorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
- Samuel Singer, M.D. · Principal investigator
RecruitingMemorial Sloan Kettering Nassau (Consent and Followup)
Rockville Centre, New York, United States
- Sam Singer, MD · Contact212-639-2940
Recruiting
Study team
Sponsor
Memorial Sloan Kettering Cancer Center
Study ID 02-060
Principal investigator
Singer Singer, MD
Memorial Sloan Kettering Cancer Center
CONTACT
Aimee Crago, MD, PhD
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.